Macquarie Group’s Sophiris Bio, Inc. SPHS Stock Holding History

Macquarie Group’s Portfolio SPHS Stock Details SPHS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-3,700	Closed	-$8K	–	2568
2017 Q4	$8K	Buy	+3,700	New	+$8.05K	﹤0.01%	2328

Other funds holding SPHS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BAM

Belpointe Asset Management Reno, Nevada $2.74B AUM 20.71% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

ACM

Alpha Capital Management Austin, Texas $690M AUM 22.82% 1-Year Est. Return

Macquarie Group's SPHS Position: Q1 2018 in Review

Macquarie Group sold out of Sophiris Bio, Inc. (SPHS) in Q1 2018, closing a stake of 3,700 shares — an estimated $8K sold.

Macquarie Group first reported a position in SPHS in Q4 2017 and held it in 1 quarter. The position peaked at $8K in Q4 2017. 34 funds tracked by Wall St. Rank hold SPHS as of Q1 2018.

Macquarie Group reported no remaining Sophiris Bio, Inc. position as of Q1 2018 after selling out during the quarter.
Macquarie Group sold 3,700 Sophiris Bio, Inc. shares in Q1 2018, an estimated $8K.
Macquarie Group first reported a position in Sophiris Bio, Inc. in Q4 2017 and held it in 1 quarter.
Macquarie Group's Sophiris Bio, Inc. position peaked at $8K in Q4 2017.
34 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q1 2018.

Based on Macquarie Group's 13F filing for Q1 2018, filed 11 May 2018.